Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") entered into a global licensing agreement with Merck KGaA, Darmstadt, Germany, for the use of Biocytogen's RenMiceTM platform. Under the
BEIJING, May 24, 2022 /PRNewswire/ Eucure Biopharma, a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen"), today announced that it will present two posters